CompletedNCT00475878
Escitalopram to ease depression and support buprenorphine treatment
About this title
Read the official source — NCT00475878Medication studyAges 18–75United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- ProvidenceSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateDecember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 147
- Sponsor
- Butler Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT00475878
- Official title
Show the full official title
Antidepressants During Office-Based Buprenorphine
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Providence
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Butler Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including escitalopram and placebo.
Who was this study for?
Listed age limits: 18 years to 75 years.
